Intranasal corticosteroid and antihistamine combination

This page covers all Intranasal corticosteroid and antihistamine combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glucocorticoid receptor (fluticasone furoate); H1 histamine receptor (fexofenadine).

Targets

Glucocorticoid receptor (fluticasone furoate); H1 histamine receptor (fexofenadine)

Marketed (1)

• Fluticasone furoate and fexofenadine · GlaxoSmithKline · Allergy/Immunology
  This combination reduces allergic inflammation through a corticosteroid that suppresses immune response in the nasal airways and an antihistamine that blocks histamine receptors.

Patent intelligence

• intranasal corticosteroid and antihistamine combination patent landscape — aggregated cliff calendar, attackable patents, originator estates